Clinical Trial Update: Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

View source ↗

Summary

Real-world data on the use, safety, and effectiveness of nivolumab in melanoma and lung cancer from routine oncology practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Melanoma

Drugs mentioned

• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma, Lung Cancer | Status: COMPLETED